Chloe Botaine

The transition from traditional, brick-and-mortar clinics to high-definition digital consultation rooms has fundamentally redefined the patient experience within the medical cannabis sector over the last few years. While the initial legalization of cannabis focused heavily on the physical

The effectiveness of a human's internal defense system might rely more on the timing of their last meal than previously understood by modern clinical science. While scientific inquiry has traditionally focused on how chronic nutritional states, such as long-term obesity or persistent malnutrition,

The passing of J. Craig Venter in April 2026 serves as a profound catalyst for a global reassessment of how humanity interacts with the fundamental building blocks of existence, moving beyond the era of genetic discovery into one of active biological fabrication. Throughout his career, Venter

A high-resolution observation of the human body has finally replaced the era of guessing through a keyhole, transforming how biological complexity is interpreted at the cellular level. In the past, understanding the immune system was like looking at a single, blurry photograph of a crowded stadium

The silent atmosphere of a modern Indian clinic often feels more like a data processing center than a sanctuary for healing and recovery, marking a stark departure from the traditional foundations of medicine. Historically, the clinical encounter was a sacred space where the physician’s primary

In the rapidly evolving landscape of cardiovascular epidemiology, the long-standing mantra of "lower is better" regarding cholesterol is facing a significant scientific re-evaluation. Recent large-scale longitudinal data involving nearly half a million participants has revealed that the

Scientists have finally pioneered a way to smuggle potent metabolic medicine directly into cells, effectively bypassing the dangerous systemic side effects that have historically stalled pharmaceutical progress. This breakthrough centers on a sophisticated "Trojan horse" delivery system that

For a disease that quietly affects nearly half a million Americans each year, a precision antibiotic that erases Borrelia burgdorferi while leaving the microbiome intact would shift Lyme treatment from blunt-force regimens to targeted, durable care that preserves health far beyond the infection

Chloe Botaine sat down with Ivan Kairatov, a Biopharma expert with deep R&D and tech experience, to discuss the European Commission’s approval of a long-acting monoclonal antibody for RSV prevention in newborns and infants. With a single intramuscular dose designed to protect for up to five months,

Hospitals feel the squeeze as drug-resistant infections outpace discovery, while conventional screening drains time and money without delivering medicines that dissolve, distribute, and survive the real world. That pressure has pushed researchers to reimagine how drugs are created, trading